Will de Lartigue 3rd Metabolic Diseases; Breakthrough Discoveries in Diabetes & Obesity 2022

Will de Lartigue

Guillaume de Lartigue is a Principle Investigator at the Monell Chemical Senses Center leading a research programme studying the neurobiology of feeding behaviour. His lab has been at the forefront of developing pharmacological, molecular and genetic tools to visualise, map, record, and manipulate vagal sensory neurons. His team has identified previously unsuspected roles of gut-brain interoception in various aspects of higher-order feeding behaviour. His aim is to develop interoceptive therapeutics for treating obesity. Dr. de Lartigue has received many awards and honours for his work, including the Burgen Prize from the Academia Europaea, Pathways to Independence Award from the National Institutes of Health, and the Acta Physiologica award from the Scandinavian Physiological Society. He serves on the advisory board of Bariatek, and is associate editor for Peptides. He was elected as Treasurer of the Society for the Study of Ingestive Behavior (SSIB), and is currently co-Chair of the SSIB Diversity Committee. Before moving to Philadelphia in 2022, Dr. de Lartigue held independent research positions at the University of Florida, and Yale University/JB Pierce laboratory.